Cyr61 Antibodies

Santa Cruz Biotechnology features a diverse variety of Cyr61 monoclonal antibodies for advanced research in cell signaling and extracellular matrix interactions. Cyr61 Antibodies are highly effective in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cyr61, also known as CCN1, is a matricellular protein that plays a crucial role in cell adhesion, migration, and proliferation. Cyr61 drives various biological processes, including wound healing, angiogenesis, and tissue repair, making it an important target for understanding developmental biology and disease mechanisms. Dysregulation of Cyr61 has been implicated in several pathological conditions, including cancer and cardiovascular diseases. Cyr61 expression patterns serve as valuable indicators for monitoring disease progression and treatment responses. Understanding Cyr61's molecular mechanisms can lead to breakthrough therapeutic strategies for various diseases. Ongoing research continues to uncover new functions and regulatory pathways associated with Cyr61 in cellular processes. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of Cyr61's role in human health and disease development.